Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
Contact Us |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages
The FDA Drug Shortage database is currently experiencing technical difficulties and some of the information contained in the database may not reflect the current supply status.
Start Over | Back to Previous Screen
Iohexol Injection
Status: Currently in Shortage
»Date first posted:
05/09/2022
»Therapeutic Categories: Medical Imaging
GE Healthcare (Revised 08/12/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Iohexol (Omnipaque) NDC (0407-1414-98), 350 mg/1 mL, OMNIPAQUE INJECTION, SOLUTION, IV OMNIPAQUE 350mgI/ml USB PH10x500ml USA | Product Available as of July 1, 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1414-72), 350 mg/1 mL OMNIPAQUE INJECTION, SOLUTION, IV OMNIPAQUE 350mgI/ml USB IBP 10x500ml USA | Product Available as of July 1, 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1414-88), OMNIPAQUE 350 mg/1 mL, INJECTION, SOLUTION, IV 10 BOTTLE, PLASTIC in 1 BOX > 500 mL in 1 BOTTLE, PLASTIC | Product Available as of July 1, 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1414-48), 350 mg/1 mL, INJECTION, SOLUTION, IV 10 BOTTLE, PLASTIC in 1 BOX > 500 mL in 1 BOTTLE, PLASTIC | Product Available as of July 1, 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1412-10), 240 mg/1 mL, OMNIPAQUE INJECTION, SOLUTION, IV OMNIPAQUE 240mgI/ml VIAL10x 10 ml USA | Product Available as of July 1, 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1412-20), 240 mg/1 mL, OMNIPAQUE INJECTION, SOLUTION, IV OMNIPAQUE 240mgI/ml VIAL10x 20 ml USA | Product Available as of July 1, 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1414-89), 350 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1414-91), 350 mg/1 mL, OMNIPAQUE INJECTION, SOLUTION, IV OMNIPAQUE 350mgI/ml USB 10x100 ml USA | Product available as of July 1, 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1411-10), 180 mg/1 mL, OMNIPAQUE INJECTION, SOLUTION, ORAL OMNIPAQUE 180mgI/ml VIAL10x 10 ml USA | Product available as of July 1, 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1413-68), 300 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1411-20), 180 mg/1 mL, OMNIPAQUE INJECTION, SOLUTION, ORAL OMNIPAQUE 180mgI/ml VIAL10x 20 ml USA | Product available as of July 1, 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1413-72),300 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product will be available for order September 5, 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1413-89), 300 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of August. | Other | |
| Iohexol (Omnipaque) NDC (0407-1413-48), 300 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of August. | Other | |
| Iohexol (Omnipaque) NDC (0407-1416-12), 12 mg/1 mL, SOLUTION, ORAL | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1415-09), 9 mg/1 mL, SOLUTION, ORAL | Backordered. Product will be available for order September 5, 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1412-34), 240 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1412-30), 240 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1412-35), 240 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1412-33), 240 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1413-53), 300 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1413-10), 300 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1413-59), 300 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1413-65), 300 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1413-61), 300 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1413-63), 300 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product will be available for order September 5, 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1413-62), 300 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1413-66), 300 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1414-76), 350 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1413-69), 300 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1414-94), 350 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1414-93), 350 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1414-95), 350 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1412-38), 240 mg/1 mL, INJECTION, SOLUTION, IT | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1401-52), 140 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1412-40), 240 mg/1 mL, INJECTION, SOLUTION, IT | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1412-39), 240 mg/1 mL, INJECTION, SOLUTION, IT | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1413-41), 300 mg/1 mL, INJECTION, SOLUTION, IT | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1412-84), 240 mg/1 mL, INJECTION, SOLUTION, IT | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1413-42), 300 mg/1 mL, INJECTION, SOLUTION, IT | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1413-43), 300 mg/1 mL, INJECTION, SOLUTION, IT | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1413-46), 300 mg/1 mL, INJECTION, SOLUTION, IT | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1413-47), 300 mg/1 mL, INJECTION, SOLUTION, IT | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1413-86), 300 mg/1 mL, INJECTION, SOLUTION, IT | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1413-87), 300 mg/1 mL, INJECTION, SOLUTION, IT | Backordered. Product availability is likely to be impacted until the end of August. | Other | |
| Iohexol (Omnipaque) NDC (0407-1413-88), 300 mg/1 mL, INJECTION, SOLUTION, IT | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1414-41), 350 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1414-42), 350 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1414-43), 350 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1414-90), 350 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1414-44), 350 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1414-85), 350 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1414-45), 350 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1414-84), 350 mg/1 mL, INJECTION, SOLUTION, IV | Product Available as of July 1, 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1414-82), 350 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of September. | Other | |
| Iohexol (Omnipaque) NDC (0407-1414-87), 350 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of 2022. | Other | |
| Iohexol (Omnipaque) NDC (0407-1414-86), 350 mg/1 mL, INJECTION, SOLUTION, IV | Backordered. Product availability is likely to be impacted until the end of 2022. | Other |